# Vericiguat for the Inhibition of Calcific Aortic Valve Stenosis Progression

> **NCT07715279** · PHASE2 · RECRUITING · sponsor: **West China Hospital** · enrollment: 238 (estimated)

## Conditions studied

- Calcific Aortic Valve Disease
- AORTIC VALVE DISEASES
- Aortic Valve Stenosis

## Interventions

- **DRUG:** Vericiguat (BAY1021189)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07715279
- **Lead sponsor:** West China Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-09-24
- **Primary completion:** 2029-10-31
- **Final completion:** 2029-11-30
- **Target enrollment:** 238 (ESTIMATED)
- **Last updated:** 2026-09-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07715279

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07715279, "Vericiguat for the Inhibition of Calcific Aortic Valve Stenosis Progression". Retrieved via MORVS 2026-10-28 from https://api.morvs.ai/clinical/NCT07715279. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*